Neoplasm Treatment - Pakistan
Pakistan- The Neoplasm Treatment market in Pakistan is expected to witness a significant growth in revenue, with projections indicating that it will reach a staggering amount of US$615.90m by the year 2024.
- Furthermore, it is anticipated that this market will exhibit a promising annual growth rate of 5.97% from 2024 to 2029, leading to a substantial market volume of US$823.20m by 2029.
- In terms of global comparison, it is noteworthy that United States is expected to contribute the highest revenue, amounting to an impressive US$90.56bn in 2024.
- Pakistan has seen a rise in the adoption of innovative cancer treatments, making it a hub for neoplasm treatment advancements in the region.
Definition:
Neoplasm Treatment refers to the medical and surgical treatments of cancer patients who require hospitalization for their care. This includes surgeries, chemotherapy, radiation therapy, immunotherapy, and/or other treatments that require close monitoring and support from healthcare professionals. Patients will typically stay in a hospital for several days to several weeks, depending on the severity of their condition. This allows hospitals to provide the highest level of medical support and to help manage symptoms and/or side effects of the patients while they receive treatment.
Additional information:
The Neoplasm Treatments market comprises revenues and average revenue per capita. Market values represent revenues paid to hospitals by the respective healthcare payers (including VAT, if applicable). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.
In-Scope
- Inpatient treatment of cancer patients
Out-Of-Scope
- Long-term rehabilitative care
- Home-based rehabilitative care
